Evaluation of Bone Marrow Morphology is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Findings from a recent study add credence to recent World Health Organization (WHO) criteria stressing the importance of the marrow biopsy at diagnosis. Whereas it may be argued that a baseline bone marrow biopsy is not a necessary diagnostic procedure for patients with a significantly increased red cell count and a demonstrable JAK2V617F allele burden, a biopsy establishes initial degree of cellularity and fibrosis that should be used for clinical decisions during the course of the illness.


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.